Works matching DE "POLY ADP ribose"

Results: 946
    1
    2
    3

    Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy.

    Published in:
    Science Translational Medicine, 2025, v. 17, n. 797, p. 1, doi. 10.1126/scitranslmed.adr5861
    By:
    • Liu, Jiahao;
    • Jiao, Xiaofei;
    • Mu, Wei;
    • Li, Huayi;
    • Xia, Yu;
    • Wu, Yijie;
    • Zhu, Li;
    • Zhong, Qing;
    • Pan, Wen;
    • Liu, Xingzhe;
    • Xiang, Minghua;
    • Cheng, Jiali;
    • Lin, Haolong;
    • Zhao, Xuejiao;
    • Ding, Zhiyong;
    • Hu, Guang;
    • Mills, Gordon B.;
    • Ma, Ding;
    • Gao, Qinglei;
    • Fang, Yong
    Publication type:
    Article
    4
    5

    Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, p. 1, doi. 10.1038/s41698-024-00526-9
    By:
    • Walmsley, Charlotte S.;
    • Jonsson, Philip;
    • Cheng, Michael L.;
    • McBride, Sean;
    • Kaeser, Christopher;
    • Vargas, Herbert Alberto;
    • Laudone, Vincent;
    • Taylor, Barry S.;
    • Kappagantula, Rajya;
    • Baez, Priscilla;
    • Richards, Allison L.;
    • Noronha, Anne Marie;
    • Perera, Dilmi;
    • Berger, Michael;
    • Solit, David B.;
    • Iacobuzio-Donahue, Christine A.;
    • Scher, Howard I.;
    • Donoghue, Mark T. A.;
    • Abida, Wassim;
    • Schram, Alison M.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48153-x
    By:
    • Burdett, Nikki L.;
    • Willis, Madelynne O.;
    • Pandey, Ahwan;
    • Fereday, Sian;
    • Bowtell, D.;
    • Chenevix-Trench, G.;
    • Green, A.;
    • Webb, P.;
    • DeFazio, A.;
    • Gertig, D.;
    • Traficante, N.;
    • Fereday, S.;
    • Moore, S.;
    • Hung, J.;
    • Harrap, K.;
    • Sadkowsky, T.;
    • Pandeya, N.;
    • Malt, M.;
    • Mellon, A.;
    • Robertson, R.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Genome-wide CRISPR/ Cas9 screening for drug resistance in tumors.

    Published in:
    Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1284610
    By:
    • Zhongyan Zhang;
    • Hailiang Wang;
    • Qian Yan;
    • Jinwei Cui;
    • Yubin Chen;
    • Shiye Ruan;
    • Jiayu Yang;
    • Zelong Wu;
    • Mingqian Han;
    • Shanzhou Huang;
    • Qi Zhou;
    • Chuanzhao Zhang;
    • Baohua Hou
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Genes de predisposición al cáncer de mama.

    Published in:
    Salud Uninorte, 2018, v. 34, n. 3, p. 766
    By:
    • Pablo Orozco-Hernández, Juan;
    • Stiven Marín-Medina, Daniel;
    • Martínez-Muñoz, Manuel A.;
    • Martínez, José W.
    Publication type:
    Article
    47
    48
    49
    50